TrademarkDir
CHANGING THE COURSE OF AUTOIMMUNE DISEASE
LIVE

Serial Number

88907284

Owner

AURINIA PHARMACEUTICALS INC.

Attorney

Matthew R. Wilmot

Filing Date

May 8, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CHANGING THE COURSE OF AUTOIMMUNE DISEASE Trademark

Serial Number: 88907284 • Registration: 7781475

CHANGING THE COURSE OF AUTOIMMUNE DISEASE is a trademark filed by AURINIA PHARMACEUTICALS INC. on May 8, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

AURINIA PHARMACEUTICALS INC. (34 trademarks)

1203-4464 Markham St.

Entity Type: 11

Trademark Details

Filing Date

May 8, 2020

Registration Date

May 6, 2025

Published for Opposition

March 18, 2025

Goods & Services

Medical information services, namely, providing health and medical information in the field of diagnostic and treatment of autoimmune disorders, kidney disorders, opthamalogical disorders and lupus nephritis; conducting medical studies in the field of autoimmune disorders, kidney disorders, opthamalogical disorders and lupus nephritis; medical evaluation services, namely, conducting patients studies and functional assessment programs for patients receiving medical therapy services for purposes of guiding treatment and assessment program effectiveness

Research and development of medicinals and pharmaceuticals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 6, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 6, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 12, 2025 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 25, 2025 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 25, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 21, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 21, 2025 CRFA
ASSIGNED TO LIE
Feb 21, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 13, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 22, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 22, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 22, 2024 CNSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 12, 2024 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 15, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 15, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jul 15, 2023 CNSL
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 12, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 14, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 13, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 8, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 29, 2020 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 29, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 29, 2020 GNSL
SUSPENSION LETTER WRITTEN
Jun 29, 2020 CNSL
ASSIGNED TO EXAMINER
Jun 25, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 20, 2020 NWOS
NEW APPLICATION ENTERED
May 12, 2020 NWAP

Related Trademarks

More from this Owner

LUPUS NEPHRITIS PEER CONNECT

LUPUS NEPHRITIS PEER CONNECT

LUPUS NEPHRITIS PEER CONNECT

LUPUS NEPHRITIS PEER CONNECT

LOSING MORE THAN TIME

LOSING MORE THAN TIME

LOSING MORE THAN TIME

LOSING MORE THAN TIME

LOSING MORE THAN TIME

LOSING MORE THAN TIME

ENLIGHT-LN

ENLIGHT-LN